ReShape Lifesciences Inc. Signs Material Definitive Agreement
Ticker: HIND · Form: 8-K · Filed: Apr 21, 2025 · CIK: 1427570
| Field | Detail |
|---|---|
| Company | Reshape Lifesciences Inc. (HIND) |
| Form Type | 8-K |
| Filed Date | Apr 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, definitive-agreement
TL;DR
RESHAPE SIGNS NEW DEAL - DETAILS TO FOLLOW
AI Summary
On April 15, 2025, ReShape Lifesciences Inc. entered into a material definitive agreement. The filing does not provide specific details on the agreement's nature or any associated dollar amounts. The company, formerly known as Obalon Therapeutics Inc., is incorporated in Delaware and headquartered in San Clemente, California.
Why It Matters
This filing indicates a significant new development for ReShape Lifesciences Inc., potentially impacting its business operations and future financial performance.
Risk Assessment
Risk Level: medium — The lack of specific details in the filing regarding the material definitive agreement introduces uncertainty about its terms and potential impact.
Key Players & Entities
- ReShape Lifesciences Inc. (company) — Registrant
- Obalon Therapeutics Inc. (company) — Former company name
- April 15, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Clemente, California (location) — Principal executive offices address
FAQ
What is the nature of the material definitive agreement entered into by ReShape Lifesciences Inc. on April 15, 2025?
The filing states that ReShape Lifesciences Inc. entered into a material definitive agreement on April 15, 2025, but does not provide specific details about its nature.
Are there any financial terms or dollar amounts associated with this new agreement mentioned in the filing?
No, the provided text of the 8-K filing does not mention any specific dollar amounts or financial terms related to the material definitive agreement.
When was ReShape Lifesciences Inc. formerly known as?
ReShape Lifesciences Inc. was formerly known as Obalon Therapeutics Inc., with a date of name change in 20080220.
Where are ReShape Lifesciences Inc.'s principal executive offices located?
ReShape Lifesciences Inc.'s principal executive offices are located at 18 Technology Drive, Suite 110, Irvine, CA 92618.
What is the SEC file number for ReShape Lifesciences Inc.'s 8-K filing?
The SEC file number for ReShape Lifesciences Inc.'s 8-K filing is 001-37897.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 21, 2025 regarding ReShape Lifesciences Inc. (HIND).